Bellicum Pharmaceuticals (NASDAQ: BLCM)and bluebird bio (NASDAQ: BLUE)are both clinical-stage biotechs that are developing cutting-edge therapies to treat cancer and other diseases. But the fortunes of these two biotechs have been very different over the last 12 months. Bellicum stock is down 37% during the period, while Bluebird's share price has soared more than 125%.
Better Buy: Bellicum Pharmaceuticals, Inc. vs. bluebird bio
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться